Targeting Spike Glycans to Inhibit SARS-CoV2 Viral Entry.

Guseman, Alex J; Rennick, Linda J; Nambulli, Sham; Roy, Chandra N; Martinez, David R; Yang, Darian T; Bhinderwhala, Fatema; Vergara, Sandra; Baric, Ralph S; Ambrose, Zandrea; Duprex, W Paul; Gronenborn, Angela M.

Affiliation

Guseman AJ; Department of Structural Biology, University of Pittsburgh School of Medicine, Pittsburgh PA, USA.
Rennick LJ; Center for Vaccine Research, University of Pittsburgh, Pittsburgh PA, USA.
Nambulli S; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh PA, USA.
Roy CN; Center for Vaccine Research, University of Pittsburgh, Pittsburgh PA, USA.
Martinez DR; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh PA, USA.
Yang DT; Center for Vaccine Research, University of Pittsburgh, Pittsburgh PA, USA.
Bhinderwhala F; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh PA, USA.
Vergara S; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Baric RS; Department of Structural Biology, University of Pittsburgh School of Medicine, Pittsburgh PA, USA.
Ambrose Z; Department of Structural Biology, University of Pittsburgh School of Medicine, Pittsburgh PA, USA.
Duprex WP; Department of Structural Biology, University of Pittsburgh School of Medicine, Pittsburgh PA, USA.
Gronenborn AM; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

bioRxiv ; 2022 Dec 22.

Article in En | MEDLINE | ID: mdl-36597530

Full text: 1 Database: MEDLINE Language: En Journal: BioRxiv Year: 2022 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Language: En Journal: BioRxiv Year: 2022 Type: Article Affiliation country: United States